Shattuck Labs announces a poster presentation on SL-325 for inflammatory bowel disease at the 2025 Crohn’s and Colitis Congress. Shattuck Labs, Inc., a biotechnology company focused on ...
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback